Pittsburgh, Pennsylvania, United States - Monday, July 27th 2015 [ME NewsWire]Cellogique Corporation is pleased to announce their newly established partnership with Vertical Progress Trading Company. Cellogique Corporation has granted Vertical Progress Trading Company exclusive distribution of Obagi Medical Products, a division of Valeant Pharmaceuticals.
The Vertical Progress team notes, “Obagi is a world-renowned brand providing an extensive range of skin care products. We are proud to include Obagi in our portfolio and eager to make the products widely available to our customers across the region.”
“Vertical Progress’s experience and expansive reach in the UAE’s market combined with our shared commitment to providing the best products available give us the confidence to say that our partnership will be nothing short of a success,” says Mr. Mazen Youssef, president and CEO of Cellogique Corporation. “We are thrilled to be working with a well-established and reputable company like Vertical Progress and look forward to serving the UAE together.”
Vertical Progress Trading Company
Vertical Progress Trading Company specializes in the distribution of high-end skin care, dermatology, and cosmetic products. Focusing their expertise throughout the UAE, Vertical Progress is devoted to bringing to market the very best safe and effective products. Vertical Progress’s reach within the UAE is widespread; making the top skin care products available to patients seeking solutions to their skin care concerns.
Vertical Progress Trading Company – Headquartered in Dubai, UAE
Obagi Medical Products, A Division of Valeant Pharmaceuticals
All ages. All skin types. There’s an Obagi for everyone. “Obagi for Life” is their commitment to each patients and a lifetime of beautiful, healthy-looking skin. Their role as a worldwide leader in skin health is based on a belief that regardless of age or skin type, there truly is an Obagi for everyone.
Obagi Medical Products, Inc., is a global specialty pharmaceutical company founded by leading skin care experts in 1988, and is now a division of Valeant Pharmaceuticals International, Inc. Obagi products are designed to minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage and are primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals.
Obagi Medical Products, Inc. – Headquartered in Long Beach, California, USA
obagi.com
Cellogique Corporation
Cellogique Corporation has been pioneering the world of cosmetic surgery, medical aesthetics, and skin health for several years throughout the Middle East region. Cellogique Corporation’s innovative approach on medical aesthetics led to the concept and development of Obagi MediSpas. Cellogique Corporation and Obagi MediSpas are committed to providing the best in cosmetic treatments, procedures, and products that are both effective and safe. As a leader in aesthetic medicine, Obagi MediSpas provide skin health restoration according to the Obagi philosophy to create and maintain healthy skin for all patients.
The state of the art facilities of Obagi MediSpas offer the very best in aesthetic medicine, from restorative and therapeutic treatments to the latest laser technologies. Obagi MediSpas provide patients of any age and skin type with cutting edge services that focus on skin health and overall wellness. Obagi MediSpas boast a clean, chic, and comfortable environment to accommodate every patient.
Cellogique Corporation and Obagi MediSpas carefully select an expert team of dermatologists and cosmetic and plastic surgeons, trained in the United States under the world renowned Dr. Suzan Obagi. The physicians and highly skilled healthcare professionals are well equipped to provide the world-class care and guidance necessary to achieve healthy skin and overall wellness.
Cellogique Corporation – Headquartered in Pittsburgh, Pennsylvania, USA
cellogique.com
Contacts
Assaad Atallah
+971 04 299 8550
Fax: +971 04 2998 551
info@verticalprogress.ae
assaad.attallah@cellogique.ae
Permalink: http://www.me-newswire.net/news/15243/en
No comments:
Post a Comment